Schedule 13G ownership disclosure
Freeline Therapeutics Holdings plc
Security class unavailable
Event date: 2020-08-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-220422
- Form type
- SC 13G
- Filer
- Freeline Therapeutics Holdings plc
- CIK
- CIK 1810031
- Filed
- Aug 14, 2020
- Reporting period
- Aug 11, 2020
- Description
- Schedule 13G beneficial ownership